 |
Site Partnering Relationship
Client: GlaxoSmithKline Location: Worthing, UK Status : Commenced early 2001; Contract signing October 2001 Scope of Work: Partnership with GSK to execute, from inception to beneficial operation, all Projects on the site capital programme Project Value: Capital programme range £15m to £25m per annum
Contact 

+44 (0)1489 614422 | 

+1 908 429 9100 |
|
|

Features:
- Integrated Capital engineering Team (CT) with approx 30 from AK pharmaceuticals - all disciplines including construction management
- Separate AK pharmaceuticals site Validation team who provide full validation services to both CT & other site business units
- Pre- & post-sanction CT project processes & procedures developed in first 6 months of partnership to effectively control & project manage the capital programme
- Best of GSK & AK pharmaceuticals processes & procedures used to add maximum value in CT practices
- Project Database developed for CT projects control
- Projects currently in range £20k to £5m
- Small projects team being developed to handle projects < £20k
- CT located & work executed in dedicated on-site offices
- Contract has incentivisation opportunities included for appropriate projects
- KPIs being developed to measure added value of the partnership
Scope:
- Upgrade and modification of sterile manufacturing areas
- Primary bulk drug manufacturing plant & equipment projects
- Site remediation planning and implementation
- Disinvestment of various existing buildings
- Upgrading existing sterile production areas to meet current regulations, including provision of new HVAC
- Solvent recovery plant and control systems modification
- Secondary manufacturing and packaging equipment upgrading
- Validation services for new projects
- Retrospective validation studies & implementation of programmes
- Site records organisation and support
|